Request for Covid-19 Impact Assessment of this Report
The United States Afutuzumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Afutuzumab market, reaching US$ million by the year 2028. As for the Europe Afutuzumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Afutuzumab players cover BOC Sciences, Carbosynth, Roche Group, and TargetMol Chemicals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Afutuzumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Patent
Generic
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Chronic Lymphocytic Leukemia
Follicular Lymphoma
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
BOC Sciences
Carbosynth
Roche Group
TargetMol Chemicals
Wonda Science
Absin Bioscience
Chunchuang (Wuhan) Technology
Hubei Kele Fine Chemical
Jiangxi Ruiweier Biotechnology
Qingdao Jieshikang Biotechnology
Shanghai Biochempartner
Shanghai Macklin Biochemical
Shanghai Qiming Biotechnology
Shanghai Saimai Biotechnology
Shanghai Shize Biological Technology
Shanghai Yifei Biotechnology
Shanghai Yu'ang Chemical
Tianmen Hengchang Chemical
Wuhan Sunrise Technology Development
Wuhan Yingnuo Pharmaceutical Technology
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Afutuzumab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Afutuzumab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Afutuzumab by Country/Region, 2017, 2022 & 2028
2.2 Afutuzumab Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Afutuzumab Sales by Type
2.3.1 Global Afutuzumab Sales Market Share by Type (2017-2022)
2.3.2 Global Afutuzumab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Afutuzumab Sale Price by Type (2017-2022)
2.4 Afutuzumab Segment by Application
2.4.1 Chronic Lymphocytic Leukemia
2.4.2 Follicular Lymphoma
2.5 Afutuzumab Sales by Application
2.5.1 Global Afutuzumab Sale Market Share by Application (2017-2022)
2.5.2 Global Afutuzumab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Afutuzumab Sale Price by Application (2017-2022)
3 Global Afutuzumab by Company
3.1 Global Afutuzumab Breakdown Data by Company
3.1.1 Global Afutuzumab Annual Sales by Company (2020-2022)
3.1.2 Global Afutuzumab Sales Market Share by Company (2020-2022)
3.2 Global Afutuzumab Annual Revenue by Company (2020-2022)
3.2.1 Global Afutuzumab Revenue by Company (2020-2022)
3.2.2 Global Afutuzumab Revenue Market Share by Company (2020-2022)
3.3 Global Afutuzumab Sale Price by Company
3.4 Key Manufacturers Afutuzumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Afutuzumab Product Location Distribution
3.4.2 Players Afutuzumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Afutuzumab by Geographic Region
4.1 World Historic Afutuzumab Market Size by Geographic Region (2017-2022)
4.1.1 Global Afutuzumab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Afutuzumab Annual Revenue by Geographic Region
4.2 World Historic Afutuzumab Market Size by Country/Region (2017-2022)
4.2.1 Global Afutuzumab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Afutuzumab Annual Revenue by Country/Region
4.3 Americas Afutuzumab Sales Growth
4.4 APAC Afutuzumab Sales Growth
4.5 Europe Afutuzumab Sales Growth
4.6 Middle East & Africa Afutuzumab Sales Growth
5 Americas
5.1 Americas Afutuzumab Sales by Country
5.1.1 Americas Afutuzumab Sales by Country (2017-2022)
5.1.2 Americas Afutuzumab Revenue by Country (2017-2022)
5.2 Americas Afutuzumab Sales by Type
5.3 Americas Afutuzumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Afutuzumab Sales by Region
6.1.1 APAC Afutuzumab Sales by Region (2017-2022)
6.1.2 APAC Afutuzumab Revenue by Region (2017-2022)
6.2 APAC Afutuzumab Sales by Type
6.3 APAC Afutuzumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Afutuzumab by Country
7.1.1 Europe Afutuzumab Sales by Country (2017-2022)
7.1.2 Europe Afutuzumab Revenue by Country (2017-2022)
7.2 Europe Afutuzumab Sales by Type
7.3 Europe Afutuzumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Afutuzumab by Country
8.1.1 Middle East & Africa Afutuzumab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Afutuzumab Revenue by Country (2017-2022)
8.2 Middle East & Africa Afutuzumab Sales by Type
8.3 Middle East & Africa Afutuzumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Afutuzumab
10.3 Manufacturing Process Analysis of Afutuzumab
10.4 Industry Chain Structure of Afutuzumab
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Afutuzumab Distributors
11.3 Afutuzumab Customer
12 World Forecast Review for Afutuzumab by Geographic Region
12.1 Global Afutuzumab Market Size Forecast by Region
12.1.1 Global Afutuzumab Forecast by Region (2023-2028)
12.1.2 Global Afutuzumab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Afutuzumab Forecast by Type
12.7 Global Afutuzumab Forecast by Application
13 Key Players Analysis
13.1 BOC Sciences
13.1.1 BOC Sciences Company Information
13.1.2 BOC Sciences Afutuzumab Product Offered
13.1.3 BOC Sciences Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 BOC Sciences Main Business Overview
13.1.5 BOC Sciences Latest Developments
13.2 Carbosynth
13.2.1 Carbosynth Company Information
13.2.2 Carbosynth Afutuzumab Product Offered
13.2.3 Carbosynth Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Carbosynth Main Business Overview
13.2.5 Carbosynth Latest Developments
13.3 Roche Group
13.3.1 Roche Group Company Information
13.3.2 Roche Group Afutuzumab Product Offered
13.3.3 Roche Group Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Roche Group Main Business Overview
13.3.5 Roche Group Latest Developments
13.4 TargetMol Chemicals
13.4.1 TargetMol Chemicals Company Information
13.4.2 TargetMol Chemicals Afutuzumab Product Offered
13.4.3 TargetMol Chemicals Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 TargetMol Chemicals Main Business Overview
13.4.5 TargetMol Chemicals Latest Developments
13.5 Wonda Science
13.5.1 Wonda Science Company Information
13.5.2 Wonda Science Afutuzumab Product Offered
13.5.3 Wonda Science Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Wonda Science Main Business Overview
13.5.5 Wonda Science Latest Developments
13.6 Absin Bioscience
13.6.1 Absin Bioscience Company Information
13.6.2 Absin Bioscience Afutuzumab Product Offered
13.6.3 Absin Bioscience Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Absin Bioscience Main Business Overview
13.6.5 Absin Bioscience Latest Developments
13.7 Chunchuang (Wuhan) Technology
13.7.1 Chunchuang (Wuhan) Technology Company Information
13.7.2 Chunchuang (Wuhan) Technology Afutuzumab Product Offered
13.7.3 Chunchuang (Wuhan) Technology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Chunchuang (Wuhan) Technology Main Business Overview
13.7.5 Chunchuang (Wuhan) Technology Latest Developments
13.8 Hubei Kele Fine Chemical
13.8.1 Hubei Kele Fine Chemical Company Information
13.8.2 Hubei Kele Fine Chemical Afutuzumab Product Offered
13.8.3 Hubei Kele Fine Chemical Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hubei Kele Fine Chemical Main Business Overview
13.8.5 Hubei Kele Fine Chemical Latest Developments
13.9 Jiangxi Ruiweier Biotechnology
13.9.1 Jiangxi Ruiweier Biotechnology Company Information
13.9.2 Jiangxi Ruiweier Biotechnology Afutuzumab Product Offered
13.9.3 Jiangxi Ruiweier Biotechnology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangxi Ruiweier Biotechnology Main Business Overview
13.9.5 Jiangxi Ruiweier Biotechnology Latest Developments
13.10 Qingdao Jieshikang Biotechnology
13.10.1 Qingdao Jieshikang Biotechnology Company Information
13.10.2 Qingdao Jieshikang Biotechnology Afutuzumab Product Offered
13.10.3 Qingdao Jieshikang Biotechnology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Qingdao Jieshikang Biotechnology Main Business Overview
13.10.5 Qingdao Jieshikang Biotechnology Latest Developments
13.11 Shanghai Biochempartner
13.11.1 Shanghai Biochempartner Company Information
13.11.2 Shanghai Biochempartner Afutuzumab Product Offered
13.11.3 Shanghai Biochempartner Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Shanghai Biochempartner Main Business Overview
13.11.5 Shanghai Biochempartner Latest Developments
13.12 Shanghai Macklin Biochemical
13.12.1 Shanghai Macklin Biochemical Company Information
13.12.2 Shanghai Macklin Biochemical Afutuzumab Product Offered
13.12.3 Shanghai Macklin Biochemical Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Shanghai Macklin Biochemical Main Business Overview
13.12.5 Shanghai Macklin Biochemical Latest Developments
13.13 Shanghai Qiming Biotechnology
13.13.1 Shanghai Qiming Biotechnology Company Information
13.13.2 Shanghai Qiming Biotechnology Afutuzumab Product Offered
13.13.3 Shanghai Qiming Biotechnology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shanghai Qiming Biotechnology Main Business Overview
13.13.5 Shanghai Qiming Biotechnology Latest Developments
13.14 Shanghai Saimai Biotechnology
13.14.1 Shanghai Saimai Biotechnology Company Information
13.14.2 Shanghai Saimai Biotechnology Afutuzumab Product Offered
13.14.3 Shanghai Saimai Biotechnology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Shanghai Saimai Biotechnology Main Business Overview
13.14.5 Shanghai Saimai Biotechnology Latest Developments
13.15 Shanghai Shize Biological Technology
13.15.1 Shanghai Shize Biological Technology Company Information
13.15.2 Shanghai Shize Biological Technology Afutuzumab Product Offered
13.15.3 Shanghai Shize Biological Technology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Shanghai Shize Biological Technology Main Business Overview
13.15.5 Shanghai Shize Biological Technology Latest Developments
13.16 Shanghai Yifei Biotechnology
13.16.1 Shanghai Yifei Biotechnology Company Information
13.16.2 Shanghai Yifei Biotechnology Afutuzumab Product Offered
13.16.3 Shanghai Yifei Biotechnology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Shanghai Yifei Biotechnology Main Business Overview
13.16.5 Shanghai Yifei Biotechnology Latest Developments
13.17 Shanghai Yu'ang Chemical
13.17.1 Shanghai Yu'ang Chemical Company Information
13.17.2 Shanghai Yu'ang Chemical Afutuzumab Product Offered
13.17.3 Shanghai Yu'ang Chemical Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Shanghai Yu'ang Chemical Main Business Overview
13.17.5 Shanghai Yu'ang Chemical Latest Developments
13.18 Tianmen Hengchang Chemical
13.18.1 Tianmen Hengchang Chemical Company Information
13.18.2 Tianmen Hengchang Chemical Afutuzumab Product Offered
13.18.3 Tianmen Hengchang Chemical Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Tianmen Hengchang Chemical Main Business Overview
13.18.5 Tianmen Hengchang Chemical Latest Developments
13.19 Wuhan Sunrise Technology Development
13.19.1 Wuhan Sunrise Technology Development Company Information
13.19.2 Wuhan Sunrise Technology Development Afutuzumab Product Offered
13.19.3 Wuhan Sunrise Technology Development Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Wuhan Sunrise Technology Development Main Business Overview
13.19.5 Wuhan Sunrise Technology Development Latest Developments
13.20 Wuhan Yingnuo Pharmaceutical Technology
13.20.1 Wuhan Yingnuo Pharmaceutical Technology Company Information
13.20.2 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product Offered
13.20.3 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Wuhan Yingnuo Pharmaceutical Technology Main Business Overview
13.20.5 Wuhan Yingnuo Pharmaceutical Technology Latest Developments
14 Research Findings and Conclusion
Table 1. Afutuzumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Afutuzumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Afutuzumab Sales by Type (2017-2022) & (Kg)
Table 6. Global Afutuzumab Sales Market Share by Type (2017-2022)
Table 7. Global Afutuzumab Revenue by Type (2017-2022) & ($ million)
Table 8. Global Afutuzumab Revenue Market Share by Type (2017-2022)
Table 9. Global Afutuzumab Sale Price by Type (2017-2022) & (US$/Kg)
Table 10. Global Afutuzumab Sales by Application (2017-2022) & (Kg)
Table 11. Global Afutuzumab Sales Market Share by Application (2017-2022)
Table 12. Global Afutuzumab Revenue by Application (2017-2022)
Table 13. Global Afutuzumab Revenue Market Share by Application (2017-2022)
Table 14. Global Afutuzumab Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Afutuzumab Sales by Company (2020-2022) & (Kg)
Table 16. Global Afutuzumab Sales Market Share by Company (2020-2022)
Table 17. Global Afutuzumab Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Afutuzumab Revenue Market Share by Company (2020-2022)
Table 19. Global Afutuzumab Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Afutuzumab Producing Area Distribution and Sales Area
Table 21. Players Afutuzumab Products Offered
Table 22. Afutuzumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Afutuzumab Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Afutuzumab Sales Market Share Geographic Region (2017-2022)
Table 27. Global Afutuzumab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Afutuzumab Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Afutuzumab Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Afutuzumab Sales Market Share by Country/Region (2017-2022)
Table 31. Global Afutuzumab Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Afutuzumab Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Afutuzumab Sales by Country (2017-2022) & (Kg)
Table 34. Americas Afutuzumab Sales Market Share by Country (2017-2022)
Table 35. Americas Afutuzumab Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Afutuzumab Revenue Market Share by Country (2017-2022)
Table 37. Americas Afutuzumab Sales by Type (2017-2022) & (Kg)
Table 38. Americas Afutuzumab Sales Market Share by Type (2017-2022)
Table 39. Americas Afutuzumab Sales by Application (2017-2022) & (Kg)
Table 40. Americas Afutuzumab Sales Market Share by Application (2017-2022)
Table 41. APAC Afutuzumab Sales by Region (2017-2022) & (Kg)
Table 42. APAC Afutuzumab Sales Market Share by Region (2017-2022)
Table 43. APAC Afutuzumab Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Afutuzumab Revenue Market Share by Region (2017-2022)
Table 45. APAC Afutuzumab Sales by Type (2017-2022) & (Kg)
Table 46. APAC Afutuzumab Sales Market Share by Type (2017-2022)
Table 47. APAC Afutuzumab Sales by Application (2017-2022) & (Kg)
Table 48. APAC Afutuzumab Sales Market Share by Application (2017-2022)
Table 49. Europe Afutuzumab Sales by Country (2017-2022) & (Kg)
Table 50. Europe Afutuzumab Sales Market Share by Country (2017-2022)
Table 51. Europe Afutuzumab Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Afutuzumab Revenue Market Share by Country (2017-2022)
Table 53. Europe Afutuzumab Sales by Type (2017-2022) & (Kg)
Table 54. Europe Afutuzumab Sales Market Share by Type (2017-2022)
Table 55. Europe Afutuzumab Sales by Application (2017-2022) & (Kg)
Table 56. Europe Afutuzumab Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Afutuzumab Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Afutuzumab Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Afutuzumab Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Afutuzumab Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Afutuzumab Sales by Type (2017-2022) & (Kg)
Table 62. Middle East & Africa Afutuzumab Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Afutuzumab Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Afutuzumab Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Afutuzumab
Table 66. Key Market Challenges & Risks of Afutuzumab
Table 67. Key Industry Trends of Afutuzumab
Table 68. Afutuzumab Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Afutuzumab Distributors List
Table 71. Afutuzumab Customer List
Table 72. Global Afutuzumab Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Afutuzumab Sales Market Forecast by Region
Table 74. Global Afutuzumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Afutuzumab Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Afutuzumab Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Afutuzumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Afutuzumab Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Afutuzumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Afutuzumab Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Afutuzumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Afutuzumab Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Afutuzumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Afutuzumab Sales Forecast by Type (2023-2028) & (Kg)
Table 85. Global Afutuzumab Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Afutuzumab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Afutuzumab Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Afutuzumab Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Afutuzumab Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Afutuzumab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Afutuzumab Revenue Market Share Forecast by Application (2023-2028)
Table 92. BOC Sciences Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 93. BOC Sciences Afutuzumab Product Offered
Table 94. BOC Sciences Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. BOC Sciences Main Business
Table 96. BOC Sciences Latest Developments
Table 97. Carbosynth Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 98. Carbosynth Afutuzumab Product Offered
Table 99. Carbosynth Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. Carbosynth Main Business
Table 101. Carbosynth Latest Developments
Table 102. Roche Group Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 103. Roche Group Afutuzumab Product Offered
Table 104. Roche Group Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. Roche Group Main Business
Table 106. Roche Group Latest Developments
Table 107. TargetMol Chemicals Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 108. TargetMol Chemicals Afutuzumab Product Offered
Table 109. TargetMol Chemicals Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. TargetMol Chemicals Main Business
Table 111. TargetMol Chemicals Latest Developments
Table 112. Wonda Science Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 113. Wonda Science Afutuzumab Product Offered
Table 114. Wonda Science Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Wonda Science Main Business
Table 116. Wonda Science Latest Developments
Table 117. Absin Bioscience Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 118. Absin Bioscience Afutuzumab Product Offered
Table 119. Absin Bioscience Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. Absin Bioscience Main Business
Table 121. Absin Bioscience Latest Developments
Table 122. Chunchuang (Wuhan) Technology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 123. Chunchuang (Wuhan) Technology Afutuzumab Product Offered
Table 124. Chunchuang (Wuhan) Technology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Chunchuang (Wuhan) Technology Main Business
Table 126. Chunchuang (Wuhan) Technology Latest Developments
Table 127. Hubei Kele Fine Chemical Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 128. Hubei Kele Fine Chemical Afutuzumab Product Offered
Table 129. Hubei Kele Fine Chemical Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Hubei Kele Fine Chemical Main Business
Table 131. Hubei Kele Fine Chemical Latest Developments
Table 132. Jiangxi Ruiweier Biotechnology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangxi Ruiweier Biotechnology Afutuzumab Product Offered
Table 134. Jiangxi Ruiweier Biotechnology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Jiangxi Ruiweier Biotechnology Main Business
Table 136. Jiangxi Ruiweier Biotechnology Latest Developments
Table 137. Qingdao Jieshikang Biotechnology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 138. Qingdao Jieshikang Biotechnology Afutuzumab Product Offered
Table 139. Qingdao Jieshikang Biotechnology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 140. Qingdao Jieshikang Biotechnology Main Business
Table 141. Qingdao Jieshikang Biotechnology Latest Developments
Table 142. Shanghai Biochempartner Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 143. Shanghai Biochempartner Afutuzumab Product Offered
Table 144. Shanghai Biochempartner Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 145. Shanghai Biochempartner Main Business
Table 146. Shanghai Biochempartner Latest Developments
Table 147. Shanghai Macklin Biochemical Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 148. Shanghai Macklin Biochemical Afutuzumab Product Offered
Table 149. Shanghai Macklin Biochemical Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 150. Shanghai Macklin Biochemical Main Business
Table 151. Shanghai Macklin Biochemical Latest Developments
Table 152. Shanghai Qiming Biotechnology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 153. Shanghai Qiming Biotechnology Afutuzumab Product Offered
Table 154. Shanghai Qiming Biotechnology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 155. Shanghai Qiming Biotechnology Main Business
Table 156. Shanghai Qiming Biotechnology Latest Developments
Table 157. Shanghai Saimai Biotechnology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 158. Shanghai Saimai Biotechnology Afutuzumab Product Offered
Table 159. Shanghai Saimai Biotechnology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 160. Shanghai Saimai Biotechnology Main Business
Table 161. Shanghai Saimai Biotechnology Latest Developments
Table 162. Shanghai Shize Biological Technology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 163. Shanghai Shize Biological Technology Afutuzumab Product Offered
Table 164. Shanghai Shize Biological Technology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 165. Shanghai Shize Biological Technology Main Business
Table 166. Shanghai Shize Biological Technology Latest Developments
Table 167. Shanghai Yifei Biotechnology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 168. Shanghai Yifei Biotechnology Afutuzumab Product Offered
Table 169. Shanghai Yifei Biotechnology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 170. Shanghai Yifei Biotechnology Main Business
Table 171. Shanghai Yifei Biotechnology Latest Developments
Table 172. Shanghai Yu'ang Chemical Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 173. Shanghai Yu'ang Chemical Afutuzumab Product Offered
Table 174. Shanghai Yu'ang Chemical Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 175. Shanghai Yu'ang Chemical Main Business
Table 176. Shanghai Yu'ang Chemical Latest Developments
Table 177. Tianmen Hengchang Chemical Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 178. Tianmen Hengchang Chemical Afutuzumab Product Offered
Table 179. Tianmen Hengchang Chemical Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 180. Tianmen Hengchang Chemical Main Business
Table 181. Tianmen Hengchang Chemical Latest Developments
Table 182. Wuhan Sunrise Technology Development Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 183. Wuhan Sunrise Technology Development Afutuzumab Product Offered
Table 184. Wuhan Sunrise Technology Development Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 185. Wuhan Sunrise Technology Development Main Business
Table 186. Wuhan Sunrise Technology Development Latest Developments
Table 187. Wuhan Yingnuo Pharmaceutical Technology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors
Table 188. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product Offered
Table 189. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 190. Wuhan Yingnuo Pharmaceutical Technology Main Business
Table 191. Wuhan Yingnuo Pharmaceutical Technology Latest Developments
List of Figures
Figure 1. Picture of Afutuzumab
Figure 2. Afutuzumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Afutuzumab Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Afutuzumab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Afutuzumab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Patent
Figure 10. Product Picture of Generic
Figure 11. Global Afutuzumab Sales Market Share by Type in 2021
Figure 12. Global Afutuzumab Revenue Market Share by Type (2017-2022)
Figure 13. Afutuzumab Consumed in Chronic Lymphocytic Leukemia
Figure 14. Global Afutuzumab Market: Chronic Lymphocytic Leukemia (2017-2022) & (Kg)
Figure 15. Afutuzumab Consumed in Follicular Lymphoma
Figure 16. Global Afutuzumab Market: Follicular Lymphoma (2017-2022) & (Kg)
Figure 17. Global Afutuzumab Sales Market Share by Application (2017-2022)
Figure 18. Global Afutuzumab Revenue Market Share by Application in 2021
Figure 19. Afutuzumab Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Afutuzumab Revenue Market Share by Company in 2021
Figure 21. Global Afutuzumab Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Afutuzumab Revenue Market Share by Geographic Region in 2021
Figure 23. Global Afutuzumab Sales Market Share by Region (2017-2022)
Figure 24. Global Afutuzumab Revenue Market Share by Country/Region in 2021
Figure 25. Americas Afutuzumab Sales 2017-2022 (Kg)
Figure 26. Americas Afutuzumab Revenue 2017-2022 ($ Millions)
Figure 27. APAC Afutuzumab Sales 2017-2022 (Kg)
Figure 28. APAC Afutuzumab Revenue 2017-2022 ($ Millions)
Figure 29. Europe Afutuzumab Sales 2017-2022 (Kg)
Figure 30. Europe Afutuzumab Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Afutuzumab Sales 2017-2022 (Kg)
Figure 32. Middle East & Africa Afutuzumab Revenue 2017-2022 ($ Millions)
Figure 33. Americas Afutuzumab Sales Market Share by Country in 2021
Figure 34. Americas Afutuzumab Revenue Market Share by Country in 2021
Figure 35. United States Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Afutuzumab Sales Market Share by Region in 2021
Figure 40. APAC Afutuzumab Revenue Market Share by Regions in 2021
Figure 41. China Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Afutuzumab Sales Market Share by Country in 2021
Figure 48. Europe Afutuzumab Revenue Market Share by Country in 2021
Figure 49. Germany Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Afutuzumab Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Afutuzumab Revenue Market Share by Country in 2021
Figure 56. Egypt Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Afutuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Afutuzumab in 2021
Figure 62. Manufacturing Process Analysis of Afutuzumab
Figure 63. Industry Chain Structure of Afutuzumab
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...